A major medical milestone took place in May 2025, when doctors at the Children’s Hospital of Philadelphia used CRISPR-based gene editing to treat a child with a rare genetic disorder. Unlike earlier ...
The FDA’s Marty Makary and Vinay Prasad have laid out a path for CRISPR treatments on demand. An expert weighs in on what it ...
Penn and CHOP researchers want to develop urea cycle disorder treatments using CRISPR gene-editing therapy. Get unlimited access to Inquirer.com and The Inquirer App, plus 5 articles each month to ...
Earlier this year, researchers at Children's Hospital of Philadelphia and Penn created a first-of-its-kind drug customized to a unique genetic mutation to save an infant named Baby KJ from dying of a ...
1don MSNOpinion
Ethics should lead, not play catch-up, expert emphasizes as Japan panel OKs making human embryos from stem cells
A leading bioethicist at Hiroshima University is calling for an anticipatory, rather than reactive, approach to ethics after ...
Mariah Carey, Brenda Lee and Darlene Love share the Christmas music crown, but they face competition from these new holiday ...
India Today on MSN
Sam Altman-backed startup eyes first gene-edited baby, as scientists warn this is dangerous
Silicon Valley billionaires love to chase extreme health tech. Their next obsession, after dabbling in tech to reverse aging, ...
We believe that if proven safe, this could be one of the most important health technologies of our lifetimes.' ...
In a highly anticipated article, FDA officials Vinay Prasad, M.D., and Martin Makary, M.D., outlined a novel regulatory ...
The plausible mechanism pathway "could accelerate gene therapy/editing development," analysts at William Blair said Thursday, ...
The “plausible mechanism pathway” will allow personalised drugs to reach the market sooner for patients with genetic diseases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback